Maceira D; AcademyHealth. Meeting (2005 : Boston, Mass.).
Abstr AcademyHealth Meet. 2005; 22: abstract no. 3500.
Center for the Study of the State and Society (CEDES), Health Economics, Sanchez de Bustamante 27, Buenos Aires, C1173AAA Tel. (54-11) 4861-2126 Fax (54-11) 4862-0805
RESEARCH OBJECTIVE: The goal of this paper is to understand the sources of differentiation among products in four Argentinean therapeutic classes, and their effects on price elasticities. STUDY DESIGN: Pharmaceutical markets are characterized by a high degree of product differentiation, where price, consumers income, perceived quality, and reputation interact. In addition, induced demand affects not only the impact of prices on the decision of buying a drug, but also the criteria used to prescribe it. In the Argentinean case, without patent protection, there is not a clear distinction between brand product and generics, which in turn affects the nature of competition. Marketing efforts targeting physicians (detail advertisement) consume important shares of pharmaceutical producers budgets. On the other hand, technical progress in chemical ingredients provides consumers and physicians with new alternatives of choice. POPULATION STUDIED: A discrete choice model of product differentiation is used to measure demands for antidiabetics, gastroprocinetics, prostatics and quinolons, during 1988-1995. Such demand functions start with an individual utility function, which is explained by observed prices, product characteristics, and consumers tastes. The econometric implementation takes the form of a nested logit model, where the first source of substitution is by chemical ingredient, followed by variables related to marketing/reputation. PRINCIPAL FINDINGS: The confirmed hypothesis is that reputation builder variables are consistently significant across therapeutic classes. CONCLUSIONS: The study shows a correspondence between the level of necessity of the drugs and the relative importance of chemical ingredients in the decision of consumption. IMPLICATIONS FOR POLICY, DELIVERY OR PRACTICE: The analysis of market strategies allows more precision in the definition of public policies and regulatory frame, such as control of leading companies, non competitive markets and therapeutic classes with low elasticity.
Publication Types:
Keywords:
- Biomedical Research
- Choice Behavior
- Commerce
- Drugs, Generic
- Laboratory Techniques and Procedures
- Marketing
- Patents
- Pharmaceutical Preparations
- Prescriptions, Drug
- Research
- hsrmtgs
UI: 103622963
From Meeting Abstracts